Delivery Order SPE2DR25D2104-SPE2DR26F3TPF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Mestinon 60 mg tablets (100-count units) under a firm fixed-price arrangement with a ceiling value of $6,998.47 and an ultimate completion date of November 10, 2025. This non-set-aside award represents a small-value transaction within AmerisourceBergen's extensive federal pharmaceutical supply portfolio. The place of performance is listed in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $3,104.96 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Mestinon 60 mg tablets (100-count units). This is a firm fixed price contract with an ultimate completion date of June 3, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $15,269.88 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed-price delivery order, issued on June 16, 2025, with an ultimate completion date of June 17, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,608.82, is for the supply of 4,567,875,099 units of the medication Mestinon 60 mg tablets. The contract has an ultimate completion date of April 11, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, holds a...
- The Defense Logistics Agency awarded a $25,032.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan in quantities of 30 units. The order was competitively awarded with no set-aside designation and is scheduled for completion by December 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $19,899.87 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg TimeSpan, a neurological medication used in military and veteran healthcare systems. This competitive award, issued on September 25, 2025, with completion targeted for September 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $2,026.57 delivery order to AmerisourceBergen Drug Corp for 30 units of Mestinon 180 mg Timespan on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price, non-set-aside contract represents a single pharmaceutical delivery under AmerisourceBergen's broader federal contract portfolio. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a $7,601.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in 30-count units. This non-set-aside contract, issued on December 11, 2025, with completion scheduled for December 12, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $16,635.92 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Mestinon 180 mg Timespan (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open procurement requirements. The contract has an ultimate completion date of December 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award...
- The Defense Logistics Agency issued a delivery order valued at $7,166.59 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed-price delivery order, awarded on September 11, 2025, with completion targeted for September 12, 2025, represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. The award was made through open competition with no set-aside designation, and performance will be...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3TPFDelivery Order
The Defense Logistics Agency awarded a $2,917.12 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Mestinon 60 mg, with performance in Conshohocken, Pennsylvania and a completion date of January 15, 2026. This non-set-aside contract was competitively awarded on a firm fixed-price basis. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract supports federal healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 1/13/26 |